Evolution of the Average Target: IBEX Limited

Evolution of the Target Price: IBEX Limited

Changes in Analyst Recommendations: IBEX Limited

9d100.BJvvyapBXliB_3HgE-j9dCBkwJXceuaX8y_KW3P9dSU.a_a2vpkADQ-ykgWLXN63OxMDof-JSrXvnUq-FzbOO0l8qaao4BI3B9CqEg~a63e43a80d566dfc5d97aa108f30b938
11-10 RBC Lifts Price Target on IBEX to $40 From $39, Keeps Sector Perform Rating MT
25-09-12 IBEX Rallies to All-Time High Following Higher Fiscal Q4 Results MT
25-09-12 Ibex Q4 Beat Driven by Revenue Acceleration, GenAI Adoption, RBC Says MT
25-09-12 RBC Raises Price Target on IBEX to $39 From $31, Keeps Sector Perform Rating MT
25-05-12 Baird Downgrades IBEX to Neutral From Outperform, $30 Price Target MT
25-02-07 RBC Capital Adjusts Price Target on IBEX to $24 From $21, Keeps Sector Perform Rating MT
24-09-13 RBC Raises Price Target on IBEX to $20 From $18, Keeps Sector Perform Rating MT
24-04-19 Baird Adjusts Price Target on IBEX to $20 From $21, Maintains Outperform Rating MT
23-11-10 RBC Lifts Price Target on IBEX to $19 From $18, Keeps Sector Perform Rating MT
23-11-10 Piper Sandler Downgrades IBEX to Neutral From Overweight, Price Target is $17 MT
23-09-28 Baird Adjusts Price Target on IBEX to $22 From $24, Keeps Outperform Rating MT
23-09-18 Piper Sandler Cuts Price Target on IBEX to $17 From $24, Keeps Overweight Rating MT
23-09-14 Citigroup Adjusts Price Target on IBEX to $18 From $23, Maintains Neutral Rating MT
23-09-14 Baird Adjusts Price Target on IBEX to $24 From $28, Maintains Outperform Rating MT
23-09-14 Truist Securities Adjusts IBEX Price Target to $25 From $32, Maintains Buy Rating MT
23-09-14 IBEX Downgraded by RBC to Sector Perform From Outperform, Price Target Cut to $18 From $27 MT
23-05-19 Piper Sandler Adjusts Price Target on IBEX to $24 From $32, Keeps Overweight Rating MT
23-05-18 Citigroup Adjusts Price Target on IBEX to $23 From $30, Keeps Neutral Rating MT
23-05-18 RBC Cuts Price Target on IBEX to $27 From $30, Citing 'Revenue Growth Pressures,' Decline in Peer Valuations; Outperform Rating Kept MT
23-05-18 Baird Adjusts IBEX Price Target to $28 From $32, Maintains Outperform Rating MT
23-02-16 RBC Raises Price Target on IBEX to $30 From $26, Maintains Outperform Rating MT
23-01-06 Piper Sandler Adjusts Price Target on IBEX to $29 From $27, Maintains Overweight Rating MT
22-11-18 Citigroup Raises Price Target on IBEX to $26 From $18, Maintains Neutral Rating MT
22-11-16 Truist Securities Adjusts IBEX Price Target to $27 From $22, Maintains Buy Rating MT
22-11-16 Piper Sandler Adjusts Price Target on IBEX to $27 From $20, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +12.85%
+23.96%
+22.99%
+0.17%
+49.98%
+24.18%
+18.75%
+51.96%
+43.35%
- -3.58%
Average +24.46%
Weighted average by Cap. +24.22%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
33.23USD
Average target price
37.50USD
Spread / Average Target
+12.85%
High Price Target
40.00USD
Spread / Highest target
+20.37%
Low Price Target
35.00USD
Spread / Lowest Target
+5.33%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Baird
Piper Sandler
Citigroup
Truist Securities
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
33.23USD
Average target price
37.50USD
Spread / Average Target
+12.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IBEX Stock
  4. Consensus IBEX Limited